Dimethyl sulfoxide (DMSO) & Dichloroacetate (DCA) IV Therapy

Advanced metabolic and supportive therapy options — aimed at inflammation reduction, metabolic modulation, and integrative care support. DMSO and DCA IV therapy offer adjunctive metabolic and anti-inflammatory benefits, potentially enhancing tissue repair, reducing oxidative stress, improving circulation, and supporting cellular metabolism. Administered under medical supervision, these therapies may help support chronic illness management, detoxification, metabolic therapies, or adjunctive oncology care.

What is it?

DMSO (Dimethyl Sulfoxide): a small sulfur-containing molecule first investigated in the 1960s for its anti-inflammatory, antioxidant, and membrane-penetrating properties. Clinically, DMSO IV therapy is used for pain, inflammation, vascular support, and may assist in detoxification and reduction of oxidative stress. It is an excellent carrier molecule and has been shown to increase sensitivity to cancer treatment.

DCA (Dichloroacetate Sodium): a metabolic modulator that influences cellular energy pathways. In experimental settings, DCA shifts energy production in cells from anaerobic glycolysis to mitochondrial oxidative phosphorylation. This metabolic effect has been studied for symptom control and metabolic stabilization in certain diseases.

When administered intravenously, DMSO and DCA bypass digestive metabolism, allowing for higher bioavailability and systemic effects — potentially enhancing benefits for detoxification, inflammation reduction, metabolic health, or supportive care.

The Benefits

DMSO

Potent anti-inflammatory and antioxidant effects, reducing oxidative stress and tissue irritation.
Supports vascular health — may improve circulation, reduce vascular inflammation, and support detoxification.
May aid connective tissue health by supporting cell membrane flexibility and signaling.

DCA

May help restore more efficient mitochondrial energy production over anaerobic glycolysis.
May be supportive for systemic metabolic balance, potentially improving energy, reducing metabolic stress, and assisting complex chronic conditions when integrated into a broader care plan.

As with all integrative therapies, results vary by individual, and these therapies are best used as part of a comprehensive, personalized medical plan.

Is DCA or DMSO IV Right For You?

DMSO & DCA IV therapy may be considered for individuals dealing with:

Chronic inflammation and oxidative stress
Vascular dysfunction or poor circulation
Metabolic dysregulation or mitochondrial stress
Chronic pain or inflammatory pain conditions
Supportive care alongside conventional treatments (e.g., in integrative oncology, metabolic therapy, detoxification protocols)
Complex chronic illness requiring multi-system support
Individuals seeking advanced metabolic support, detox, or anti-inflammatory care

Your physician will evaluate your health status, medical history, and lab results to determine whether DMSO or DCA therapy is appropriate.

What to Expect

Schedule & Share

Initial Consultation

Treatment Plan

Book a consultation and upload your full medical history, including current diagnoses, medications, liver and kidney labs, and treatment goals. Because DMSO and DCA can affect metabolism, detoxification, and circulation, a detailed history is essential for safe administration.

During a 60-minute consult, your physician will review your case, assess risks and benefits, and discuss whether DMSO, DCA, or a combination fits your health objectives. You’ll be informed about the experimental or supportive nature of DCA when used for metabolic or oncology-adjunctive protocols.

You’ll receive a personalized plan including number of infusions, frequency, and supportive therapies (e.g., antioxidants, mitochondrial support, hydration, detox protocols) to accompany your IV therapy.

During Treatment

DMSO Infusion: typically administered slowly over 60–90 minutes. You may experience mild garlic-like odor (temporary), slight warming, or flushing during infusion; these are common and generally well tolerated. DCA Infusion: dosing and duration depend on medical indication; when used intravenously, therapy is administered under close medical supervision with periodic monitoring of liver, nerve function, and labs. Post-infusion, patients are monitored for tolerance and given aftercare guidance, including hydration, nutrition, and supportive supplements if needed. Because these therapies may mobilize toxins or change metabolism, follow-up labs and periodic assessments are recommended.

Why Choose Upper Room Clinic

At the Upper Room Clinic, we deliver DMSO and DCA IV Therapy with rigorous clinical oversight, personalized protocols, and integrated metabolic support. Our experienced physicians assess your full medical context, tailor dosing and supportive therapies, and monitor your progress every step of the way.

We emphasize safety, transparency, and compassionate care — making sure you understand the potential benefits, limitations, and uncertainties. With our locations in Toronto and Oakville, we offer convenient access to advanced IV therapies within a professional, supportive environment.

Locations
Upper Room Clinic – Oakville
Tel: 647-910-5359
Fax: 289-644-0255
oakville@upperroomclinic.com

Upper Room Clinic – Davisville
Tel: 647-521-8024
Fax: 647-348-8024
hello@upperroomclinic.com

Tuesday to Saturday
11am-6pm

Quick Links

Services Programs locations PRICING ABOUT US

Stay connected

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.